Universal-Beteiligungs- und Servicegesellschaft’s Ironwood Pharmaceuticals IRWD Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-56,132	Closed	-$197K	–	2160
2026 Q1	$197K	Sell	56,132 -22,881	-29%	-$93.8K	﹤0.01%	1990
2025 Q4	$266K	Sell	79,013 -45,862	-37%	-$119K	﹤0.01%	1900
2025 Q3	$164K	Sell	124,875 -401,900	-76%	-$416K	﹤0.01%	2028
2025 Q2	$378K	Buy	526,775 +108,822	+26%	+$85.4K	﹤0.01%	1763
2025 Q1	$614K	Sell	417,953 -8,185	-2%	-$19.5K	﹤0.01%	1597
2024 Q4	$1.89M	Buy	+426,138	New	+$1.73M	﹤0.01%	888

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HIM

Hillsdale Investment Management Toronto, Ontario, Canada $4.39B AUM 72.96% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.43B AUM 49.04% 1-Year Est. Return

IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's IRWD Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2026, closing a stake of 56,132 shares — an estimated $197K sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in IRWD in Q4 2024 and held it in 6 quarters. The position peaked at $1.89M in Q4 2024. 123 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft reported no remaining Ironwood Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Universal-Beteiligungs- und Servicegesellschaft sold 56,132 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $197K.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Ironwood Pharmaceuticals in Q4 2024 and held it in 6 quarters.
Universal-Beteiligungs- und Servicegesellschaft's Ironwood Pharmaceuticals position peaked at $1.89M in Q4 2024.
123 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.